Fresenius Medical Care AG FMS
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.27% | 6.75% | 7.30% | 6.10% | 4.05% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.27% | 6.75% | 7.30% | 6.10% | 4.05% |
| Cost of Revenue | 2.27% | 4.37% | 5.16% | 4.61% | 4.20% |
| Gross Profit | 10.26% | 14.01% | 13.90% | 10.67% | 3.59% |
| SG&A Expenses | 2.73% | 1.62% | 4.98% | 0.83% | -0.15% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 149.90% | 97.02% | 72.88% | 68.31% | 76.15% |
| Total Operating Expenses | 2.59% | 4.25% | 5.39% | 4.23% | 3.85% |
| Operating Income | 22.09% | 35.12% | 29.17% | 27.62% | 6.16% |
| Income Before Tax | 23.07% | 37.76% | 37.53% | 50.45% | -0.09% |
| Income Tax Expenses | 20.25% | 5.82% | -3.64% | 6.51% | -17.44% |
| Earnings from Continuing Operations | 23.92% | 49.72% | 54.67% | 69.19% | 6.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -45.06% | -42.34% | -23.40% | -10.43% | 12.17% |
| Net Income | 18.43% | 51.81% | 64.46% | 91.29% | 12.94% |
| EBIT | 22.09% | 35.12% | 29.17% | 27.62% | 6.16% |
| EBITDA | 13.35% | 20.51% | 16.89% | 14.57% | 2.54% |
| EPS Basic | 26.13% | 57.95% | 67.53% | 93.25% | 13.15% |
| Normalized Basic EPS | 16.19% | 36.45% | 39.74% | 44.77% | 22.04% |
| EPS Diluted | 26.41% | 58.29% | 68.12% | 94.23% | 12.88% |
| Normalized Diluted EPS | 16.19% | 36.45% | 39.74% | 44.77% | 22.04% |
| Average Basic Shares Outstanding | -6.81% | -4.43% | -2.30% | -0.75% | -0.11% |
| Average Diluted Shares Outstanding | -6.81% | -4.43% | -2.30% | -0.75% | -0.11% |
| Dividend Per Share | 13.00% | 13.00% | 13.00% | 13.00% | 19.82% |
| Payout Ratio | -0.18% | -0.36% | -0.22% | -0.33% | 0.13% |